These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 16462713

  • 1. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.
    Gamberini MR, Fortini M, De Sanctis V, Gilli G, Testa MR.
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():285-91. PubMed ID: 16462713
    [Abstract] [Full Text] [Related]

  • 2. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR, De Sanctis V, Gilli G.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
    Gamberini MR, Fortini M, Gilli G, Testa MR, De Sanctis V.
    J Pediatr Endocrinol Metab; 1998 Oct; 11 Suppl 3():867-9. PubMed ID: 10091159
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection.
    Mowla A, Karimi M, Afrasiabi A, De Sanctis V.
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V, Eleftheriou A, Malaventura C, Thalassaemia International Federation Study Group on Growth and Endocrine Complications in Thalassaemia.
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C, Gilardini L, Pontiggia B, Morabito F, Mazzilli G, Viberti G.
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [Abstract] [Full Text] [Related]

  • 8. Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy.
    Platis O, Anagnostopoulos G, Farmaki K, Posantzis M, Gotsis E, Tolis G.
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():279-81. PubMed ID: 16462711
    [Abstract] [Full Text] [Related]

  • 9. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major.
    Suvarna J, Ingle H, Deshmukh CT.
    Indian Pediatr; 2006 May; 43(5):393-400. PubMed ID: 16735760
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M, Szafraniec K, Gilis-Januszewska A, Pach D, Krzentowska A, Szybiński Z, Huszno B.
    Przegl Lek; 2006 May; 63(9):728-32. PubMed ID: 17479858
    [Abstract] [Full Text] [Related]

  • 12. Age-specific prevalence and risk associations for impaired glucose tolerance in urban southern Indian population.
    Snehalatha C, Ramchandran A, Kapur A, Vijay V.
    J Assoc Physicians India; 2003 Aug; 51():766-9. PubMed ID: 14651135
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
    Mavrogiannaki A, Karamanos B, Manesis EK, Papatheodoridis GV, Koskinas J, Archimandritis AJ.
    J Viral Hepat; 2009 Jun; 16(6):430-6. PubMed ID: 19200136
    [Abstract] [Full Text] [Related]

  • 14. Gender differences in the prevalence and severity of bone disease in thalassaemia.
    Kyriakou A, Savva SC, Savvides I, Pangalou E, Ioannou YS, Christou S, Skordis N.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
    [Abstract] [Full Text] [Related]

  • 15. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A, Siemińska J, Górnicka B, Ziarkiewicz-Wróblewska B, Ziółkowski B, Muszyński J.
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study.
    Magliano DJ, Barr EL, Zimmet PZ, Cameron AJ, Dunstan DW, Colagiuri S, Jolley D, Owen N, Phillips P, Tapp RJ, Welborn TA, Shaw JE.
    Diabetes Care; 2008 Feb; 31(2):267-72. PubMed ID: 17989310
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of endocrine complications in beta-thalassaemia major in the Islamic Republic of Iran.
    Karamifar H, Shahriari M, Sadjadian N.
    East Mediterr Health J; 2003 Feb; 9(1-2):55-60. PubMed ID: 15562733
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The impact of genotype on endocrine complications in thalassaemia major.
    Skordis N, Michaelidou M, Savva SC, Ioannou Y, Rousounides A, Kleanthous M, Skordos G, Christou S.
    Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.